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1. Introduction 
The leaves of Mimosa pudica L. has been studied for its 
diuretic, anti-infective, wound healing, antifertility, aphrodisiac ad 
antivenom properties [1].  A decoction of the leaves exhibit 
anticonvulsant effects at 1,000 – 4,000 mg/kg in various animal 
models of seizures although this study did not reveal any mood-
stabilizing effects[2].  There is evidence on the antidepressant 
properties of the aqueous leaf extract at 6 and 8 mg/kg I.P. by the 
forced-swimming method [3].  However, no studies have been 
conducted to demonstrate the antidepressant and anxiolytic 
properties of the lyophilized aqueous leaf extract of M. pudica (LAL-
MP).  This study seeks to investivate the antidepressant and 
anxiolytic effects of LAL-MP in different models of depression and 
anxiety in mice. 
 
2. Materials and Methods 
2.1. Harvesting of Plant Material 
 The leaves of M. pudica were harvested in a farm located at 
San Carlos City, Pangasinan.  The plant was authenticated at the 
Virgen Milagrosa University Foundation Herbarium.  Leaves were 
washed with water to remove dirt and pressed dried in newspapers 
away from sunlight.  Dried leaves were pulverized using a Wiley mill.  
One kilogram of powdered leaves were extracted by exhaustive cold 
maceration in a stainless steel percolator with distilled water.  
Combined aqueous extracts were freeze-dried in a Virtis-201 
lyophilizer to yield 158.2 grams (15.8% w/w) of light brown powder 
which was designated in this study as the LAL-MP.  Fluoxetine (i.e., 
positive control) and LAL-MP were prepared as a 5% (w/v) 
suspension in 5% (w/v) acacia mucilage.       
2.2. Experimental Animals 
 Male Swiss mice weighing at least 20 grams were 
purchased from the Philippine Food and Drug Authority (Alabang, 
Muntinlupa City).  They were acclimatized at 300C with free access to 
food and water.  Experiments conformed to protocols on the humane 
handling of laboratory animals as approved by the Institutional 
Animal Care Use Committee.    
2.3. Phytochemical Analysis 
 The LAL-MP was subjected to thin-layer chromatography 
(TLC) using 1 x 6 cm silica gel 60 F254 TLC plates according to the 
methods of Guevara (2004)[4].  
2.4. Sample Dosing 
 The LAL-MP was orally adminitered, daily for 14 days, at 
doses of 50, 100, 200, 300, 400 and 500 mg/kg with 5 mice assigned 
to each dose.  Fluoxetine at 3.3 mg/kg (positive control) and 0.5 mL 
of 5% acacia mucilage (negative control) were given similarly.  
During the 14-day dosing, mice were given free access to food and 
water.  The mice were subjected to the forced swimming, tail 
suspension, elevated plus maze and locomotor activity tests on the 
14th day.  Mice were fasted overnight with free access to water before 
commencing with these tests. 
2.5. Forced Swimming Test   
 Mice were dropped individually in an 30 x 20 cms. glass 
aquarium containing water at a depth of 12 cms. and maintained at 
300C.  Using a stopwatch, the total mobility time within a duration of 
5 minutes (i.e., 300 seconds) was measured [5]. 
2.7. Tail Suspension Test 
 Mice were individually suspended at the edge of a table, 50 
cms. above the floor, by adhesive tapes placed 1 cm. from the tip of 
the tail.  The mobility time for a 5 minute (i.e., 300 seconds) 
suspension period was recorded [6]. 
2.8. Elevated Plus Maze (EPM) Test 
 The apparatus comprises of 2 open arms (35 x 5 cms.) and 
2 closed arms (30 x 5 x 15 cms.) elevated at 12 inches.  Mice were 
individually placed at the center of the maze facing one of the closed 
arms.  The number of entries into the open arms and the % of time 
spent at the open arms were measured within a 5 minute (i.e., 300 
seconds) observation period [7]. 
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2.9. Locomotor Activity 
 Mice were individually placed in an activity cage (i.e., 
actophotometer) and the activity scores were measured within a 5 
minute (i.e., 300 seconds) observation period [8]. 
2.10. Statistical Analysis 
 Means were compared by the 2-way analysis variance and 
2-tailed t-test.  Dose-response relationships were calculated by linear 
regression analysis.     
 
3. Results 
3.1. Phytochemical Screening 
 TLC analysis of LAL-MP revealed the presence of alkaloids, 
polyphenols (i.e., tannins and flavonoids), lignans, iridoids, 
triterpenes and unsaturated sterols and anthraquinones. 
3.2. Forced-swimming Test 
 Figure I compares the mobility time obtained between the 
forced swimming (FST) and tail suspension tests (TST) at various 
dose levels of LAL-MP.     
 
Figure I: Comparative Mobility Time Among Mice in Various Dose Levels of the Lyophilized Aqueous Leaf Extract of Mimosa pudica 
Between the Forced Swimming and Tail Suspension Tests  
There is evidence of a dose-mobility relationship in both 
FST and TST (r = 0.9823 and 0.9855, respectively).  There is also a 
high correspondence between the 2 tests (r = 0.9912) in terms of 
mobility time.  In both tests, significant dfference in mobility time 
compared to acacia starts at 200 mg/kg.  At 400 and 500 mg/kg, 




3.3. Elevated Plus Maze (EPM) Test 
 Figures II and III compares the number of entries and the 
% time spent in the open arms of the EPM, respectively, at various 
dose levels of LAL-MP in mice, showing a high agreement in both 
figures.  Responses at all oral dose levels (50 – 500 mg/kg) were 
significantly higher than 5% acacia.   At 400 and 500 mg/kg, the 
samples were equipotent with fluoxetine.  Figures II and III showed 
high evidence of dose-response relationships (r = 0.9910 and 0.9923, 
respectively). 
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Figure III: Comparative Percentage of Time Spent Among Mice in the Open Arms of the Elevated Plus Maze at Various Doses of the 
Lyophilized Aqueous Leaf Extract of Mimosa pudica 
 
3.4. Locomotor Activity 
 Figure IV compares the locomotor counts of mice treated with various dose levels of LAL-MP.   
Figure IV: Comparative Locomotor Activities Among Mice with Various Doses of the  Lyophilized Aqueous Leaf Extract of Mimosa 
pudica 
 
There is a good negative correspondence between 
locomotor counts and dose levels ( r = - 0.9877) to indicate high 
dose-response relationship.  The lyophilized sample at all dose levels 
(50 – 500 mg./kg) showed significantly lower locomotor counts than 
acacia.  At 400 and 500 mg/kg, the responses are comparable to 
fluoxetine (p > 0.01).   
 
4. Discussions 
 The fear due to height induces anxiety in mice when placed 
on an EPM. The ultimate manifestation of anxiety and fear is the 
decrease in locomotor activities and preference to remain at safer 
places (i.e., the 2 open arms).  Anxiolytic drugs are expected to 
increase motor activity which corresponds to an increase in the time 
spent by an individual mouse in the open arms.  The spontaneous 
decrease in basal locomotor activity counts recorded using an activity 
cage implies reduced anxiety.   
 The widespread use of FST is mainly due to its ability to 
detect a broad spectrum of antidepressant agents. The test is based 
on the observation that mice following initial escape‐oriented 
movements develop an immobile posture when placed inside an 
inescapable cylinder filled with water.  The immobility is thought to 
reflect either a failure of persistence in escape‐directed behavior (i.e., 
despair behavior) or the development of a passive behavior which is 
the loss of the ability to cope with stressful stimuli.  Increase in 
mobility characterized by swimming, aggression, escaping and the 
tendency to bite are, therefore, manifestations of anti-depressant 
effects.  Similarly, in the TST, the increase in mobility due to these 
characteristics also corresponds to antidepressant effects.     
 Antidepressant therapy includes drugs mostly affecting 
reuptake or metabolism of monoamines such as epinephrine, 
norepinephrine and most importantly, serotonin.  Recent data have 
suggest that glutamate N-methyl-D-aspartate (NMDA) receptors may 
be involved in the mechanism of antidepressant action.  Several 
studies have demonstrated that the NMDA receptor antagonists 
exhibit antidepressant activities in to rodents using the FST [9].   
Furthermore, NMDA receptor antagonists exhibit anxiolytic effects 
examined in the EPM. Thus, antidepressant and anxiolytic properties 
of NMDA receptor ligands suggest the involvement of glutamatergic 
system [10]. 
 Treatment of depression requires chronic intake of 
antidepressants to cause manifestations of therapeutic effects since 
neuronal adaptive alterations seem to participate in mechanisms 
involving antidepressants and anxiolytic drugs.  Therefore, it is 
important to examine if tolerance develops after prolonged 
treatment with an antidepressant or anxiolytic drug. The data in this 
study demonstrate that treatment with LAL-MP and fluoxetine, daily 
for 14 days, do not alter both measured behavioral responses.  
Moreover, challenge with acacia mucilage does not exhibit significant 
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5. Conclusion 
 This study shows that the lyophilized aqueous leaf extract 
of Mimosa pudica (LAL-MP) exhibit oral antidepressant and 
anxiolytic properties from 100 to 500 mg/kg.  At 400 and 500 mg/kg, 
LAL-MP is equipotent with 3.3 mg/kg of fluoxetine given orally.   
 
References 
[1] Ahmad, H., Sehgal, S., Mishra, A. and Gupta, R.  Mimosa pudica L. 
(Laajvanti): an overview.  Pharmacognosy Review, 2012; 6 (12): 
115-124. 
[2] Bum, N.E., Dawack, D.L., Schmutz, M., Rakotonirina, S.V., 
Rakotonirina, S.V., Portet, C., Jeker, A. and Herrling, P. 
Anticonvulsant Activity of Mimosa pudica decoction.  
Fitoterapia, 2004; 75 (3-4): 309-314.  
[3] Molina, M., Contreras, C.M. and Tellez, A.P.  Mimosa pudica may 
possess antidepressant actions in the rat.  Phytomedicine, 1999; 
6: 319-23.   
[4] Guevara, B.Q.  A Guidebook to Plant Screening:  Phytochemical 
and Biological, University of Santo Tomas, Manila, 2004.   
[5] Porsolt, R.D., Bertin, A. and Jalfre, M.  Behavioral despair in mice:  
a primary screening test for depression.  Arch. Int. Pharmacodyn. 
Ther. 1997; 229: 327 – 336. 
[6] Dhingra, D. and Valecha, R.  Behavioral and neuroendocrene 
effects of aqueous extract of Boerhaavia diffusa Linn. in mice 
using tail suspension and forced swim tests – a preliminary 
study.  Ind. J. Exp. Biol. 2014; 52: 53 – 59. 
[7] Shafeen, S., Reddy, S.T., Arafath, S., Nagarjuna, S. and Reddy, P.Y.  
Evaluation of anti-anxiety and antidepressant activity of Cassia 
occidentalis Leaves.  Asian J. Phar. Clin. Res. 2012; 5 (3): 47 – 50. 
[8] Alagarswamy, V., Thangathiruppathy, A., Mandal, S.C., 
Rajasekaran, S., Revathi, V.S. Pharmacological evaluation of 2-
substituted (1,3,4) thiadiazolo quinazolines.  Ind. J. Pharm. Sci. 
2006; 68 (1): 108 – 111. 
[9] Redmond, A.M., Kelly, G.P. and Leonard, B.E.  Behavioral and 
neurochemical effects of dizocilpine in the olfactory 
bulbectomized rat model of depression.  Pharmacol. Biochem. 
Behav. 1997; 58: 355 – 359. 
[10] Pilc, A., Klodzinska, A. and Nowak, G.  A role of glutamate in the 
treatment of anxiety and depression: focus on group 1 
metabotropic gluatamate (mGlu) receptors.  Drugs Future 2002; 
27: 753 – 763. 
  
 
 
